康基醫療(09997.HK)年度純利增長21.2%至2.5億元 末期息4.4港仙
格隆匯3月25日丨康基醫療(09997.HK)發佈公吿,截至2020年12月31日年度,公司收入5.11億元人民幣,同比增長1.6%;毛利4.31億元,同比增長2%;公司擁有人應占淨利潤2.5億元,同比增長21.2%;每股盈利26.27分,末期股息每股4.4港仙。
於2020年第一季度,公司的銷售額主要受到COVID-19疫情的影響,並被該年餘下期間的逐漸復甦所抵銷。
集團截至2020年12月31日止年度的利潤下降20.7%,乃主要由於非經常性及非經營開支。撇除上市開支人民幣3230萬元、以股份為基礎的付款開支人民幣1800萬元以及匯兑虧損影響淨額人民幣2500萬元,截至2020年12月31日止年度的非《香港財務報吿準則》經調整利潤相較於2019年增加3.1%至人民幣3.345億元。
母公司擁有人應占利潤增加21.2%,乃主要由於公司為籌備於香港聯合交易所有限公司主板上市而於2020年3月重組,導致抵銷非控股權益(約36.0%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.